{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T19:45:59Z","timestamp":1793562359263,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Danish Government"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00277-020-04356-0","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T19:03:54Z","timestamp":1609959834000},"page":"2311-2323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Health-related quality of life in patients with multiple myeloma participating in a multidisciplinary rehabilitation program"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-3870","authenticated-orcid":false,"given":"Lene Kongsgaard","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Faebo","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Jarlbaek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"6","key":"4356_CR1","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV (2008) Multiple myeloma. Blood 111(6):2962\u20132972. https:\/\/doi.org\/10.1182\/blood-2007-10-078022","journal-title":"Blood"},{"issue":"Supplement 1","key":"4356_CR2","first-page":"537","volume":"101","author":"N Abildgaard","year":"2016","unstructured":"Abildgaard N, Vangsted A, Gregersen H, Frost Andersen N, Schou Pedersen R, Plesner T, Troellund Pedersen P, Frederiksen M, Froelund U, Helleberg C, Salamo M, Holmstroem M, Wirenfeldt Klausen T, Gimsing P (2016) Improvement of overall survival in Danish multiple myeloma patients after 2008; a population-based study from the Danish National Multiple Myeloma Registry. Haematologica 101(Supplement 1):537","journal-title":"Haematologica"},{"issue":"5","key":"4356_CR3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV (2014) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28(5):1122\u20131128. https:\/\/doi.org\/10.1038\/leu.2013.313","journal-title":"Leukemia"},{"issue":"10","key":"4356_CR4","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/s41375-019-0561-2","volume":"33","author":"AH Bazarbachi","year":"2019","unstructured":"Bazarbachi AH, Al Hamed R, Malard F, Harousseau JL, Mohty M (2019) Relapsed refractory multiple myeloma: a comprehensive overview. Leukemia 33(10):2343\u20132357. https:\/\/doi.org\/10.1038\/s41375-019-0561-2","journal-title":"Leukemia"},{"issue":"12","key":"4356_CR5","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG, Miguel JF (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538\u2013e548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"issue":"1","key":"4356_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78(1):21\u201333. https:\/\/doi.org\/10.4065\/78.1.21","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"4356_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/ejh.12790","volume":"97","author":"C Ramsenthaler","year":"2016","unstructured":"Ramsenthaler C, Kane P, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2016) Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis. Eur J Haematol 97(5):416\u2013429. https:\/\/doi.org\/10.1111\/ejh.12790","journal-title":"Eur J Haematol"},{"issue":"2","key":"4356_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00520-013-1991-4","volume":"22","author":"K Jordan","year":"2014","unstructured":"Jordan K, Proskorovsky I, Lewis P, Ishak J, Payne K, Lordan N, Kyriakou C, Williams CD, Peters S, Davies FE (2014) Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study. Support Care Cancer 22(2):417\u2013426. https:\/\/doi.org\/10.1007\/s00520-013-1991-4","journal-title":"Support Care Cancer"},{"key":"4356_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12885-016-2410-2","volume":"16","author":"C Ramsenthaler","year":"2016","unstructured":"Ramsenthaler C, Osborne TR, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2016) The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer 16:427. https:\/\/doi.org\/10.1186\/s12885-016-2410-2","journal-title":"BMC Cancer"},{"issue":"5","key":"4356_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpainsymman.2012.11.003","volume":"46","author":"E Boland","year":"2013","unstructured":"Boland E, Eiser C, Ezaydi Y, Greenfield DM, Ahmedzai SH, Snowden JA (2013) Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. J Pain Symptom Manag 46(5):671\u2013680. https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.11.003","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"4356_CR11","first-page":"117","volume":"66","author":"D Priscilla","year":"2011","unstructured":"Priscilla D, Hamidin A, Azhar MZ, Noorjan KON, Salmiah MS, Bahariah K (2011) Quality of life among patients with hematological cancer in a Malaysian hospital. Med J Malays 66(2):117\u2013120","journal-title":"Med J Malays"},{"issue":"1","key":"4356_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/pon.1710","volume":"20","author":"A Molassiotis","year":"2011","unstructured":"Molassiotis A, Wilson B, Blair S, Howe T, Cavet J (2011) Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-oncology 20(1):88\u201397. https:\/\/doi.org\/10.1002\/pon.1710","journal-title":"Psycho-oncology"},{"issue":"5","key":"4356_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/0269216319833588","volume":"33","author":"C Ramsenthaler","year":"2019","unstructured":"Ramsenthaler C, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2019) Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: a prospective, multi-centre longitudinal study. Palliat Med 33(5):541\u2013551. https:\/\/doi.org\/10.1177\/0269216319833588","journal-title":"Palliat Med"},{"issue":"10","key":"4356_CR14","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/pon.3284","volume":"22","author":"J Lamers","year":"2013","unstructured":"Lamers J, Hartmann M, Goldschmidt H, Brechtel A, Hillengass J, Herzog W (2013) Psychosocial support in patients with multiple myeloma at time of diagnosis: who wants what? Psychooncology 22(10):2313\u20132320. https:\/\/doi.org\/10.1002\/pon.3284","journal-title":"Psychooncology"},{"issue":"5","key":"4356_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1600-0609.2008.01126.x","volume":"81","author":"K Strasser-Weippl","year":"2008","unstructured":"Strasser-Weippl K, Ludwig H (2008) Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma. Eur J Haematol 81(5):374\u2013379. https:\/\/doi.org\/10.1111\/j.1600-0609.2008.01126.x","journal-title":"Eur J Haematol"},{"key":"4356_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/pon.3478","volume":"23","author":"J Zabora","year":"2014","unstructured":"Zabora J, Buzaglo J, Kennedy V, Richards T, Schapmire T, Zebrack B, Ghobrial I (2014) Linking psychosocial care to the disease continuum in patients with multiple myeloma and their family caregivers. Psycho-oncology 23:110\u2013111. https:\/\/doi.org\/10.1002\/pon.3478","journal-title":"Psycho-oncology"},{"issue":"1","key":"4356_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejh.12882","volume":"99","author":"LK Nielsen","year":"2017","unstructured":"Nielsen LK, Jarden M, Andersen CL, Frederiksen H, Abildgaard N (2017) A systematic review of health-related quality of life in longitudinal studies of myeloma patients. Eur J Haematol 99(1):3\u201317. https:\/\/doi.org\/10.1111\/ejh.12882","journal-title":"Eur J Haematol"},{"key":"4356_CR18","unstructured":"REHPA The Danish Knowlegde Centre for Rehabilitation and Pallitive Care. Accessed 24 Apr 2019"},{"issue":"5","key":"4356_CR19","doi-asserted-by":"publisher","first-page":"e12865","DOI":"10.1111\/ecc.12865","volume":"27","author":"KM Pedersen","year":"2018","unstructured":"Pedersen KM, Zangger G, Brochmann N, Gronfeldt BM, Zwisler AD, Hasselbalch HC, Tang LH (2018) The effectiveness of exercise-based rehabilitation to patients with myeloproliferative neoplasms-an explorative study. Eur J Cancer Care 27(5):e12865. https:\/\/doi.org\/10.1111\/ecc.12865","journal-title":"Eur J Cancer Care"},{"issue":"8","key":"4356_CR20","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/s1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Blade J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Goldschmidt H, Spencer A, Hou J, Chng WJ, Usmani SZ, Zamagni E, Shimizu K, Jagannath S, Johnsen HE, Terpos E, Reiman A, Kyle RA, Sonneveld P, Richardson PG, McCarthy P, Ludwig H, Chen W, Cavo M, Harousseau JL, Lentzsch S, Hillengass J, Palumbo A, Orfao A, Rajkumar SV, Miguel JS, Avet-Loiseau H (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17(8):e328\u2013e346. https:\/\/doi.org\/10.1016\/s1470-2045(16)30206-6","journal-title":"Lancet Oncol"},{"issue":"3","key":"4356_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.0902-4441.2003.00195.x","volume":"72","author":"N Gulbrandsen","year":"2004","unstructured":"Gulbrandsen N, Hjermstad MJ, Wisloff F, Nordic Myeloma Study G (2004) Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. Eur J Haematol 72(3):172\u2013180. https:\/\/doi.org\/10.1046\/j.0902-4441.2003.00195.x","journal-title":"Eur J Haematol"},{"issue":"2","key":"4356_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/10428194.2019.1666381","volume":"61","author":"H Ludwig","year":"2020","unstructured":"Ludwig H, Ponisch W, Knop S, Egle A, Hinke A, Schreder M, Lechner D, Hajek R, Gunsilius E, Petzer A, Weisel K, Niederwieser D, Einsele H, Willenbacher W, Rumpold H, Pour L, Jelinek T, Krenosz KJ, Meckl A, Nolte S, Melchardt T, Greil R, Zojer N (2020) Quality of life in patients with relapsed\/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and comparison to the general population. Leuk Lymphoma 61(2):377\u2013386. https:\/\/doi.org\/10.1080\/10428194.2019.1666381","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4356_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-0609.2012.01831.x","volume":"89","author":"F Mols","year":"2012","unstructured":"Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, van de Poll-Franse LV (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89(4):311\u2013319. https:\/\/doi.org\/10.1111\/j.1600-0609.2012.01831.x","journal-title":"Eur J Haematol"},{"issue":"2","key":"4356_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","volume":"83","author":"AT Johnsen","year":"2009","unstructured":"Johnsen AT, Tholstrup D, Petersen MA, Pedersen L, Groenvold M (2009) Health related quality of life in a nationally representative sample of haematological patients. Eur J Haematol 83(2):139\u2013148. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01250.x","journal-title":"Eur J Haematol"},{"issue":"2","key":"4356_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00520-012-1548-y","volume":"21","author":"S Acaster","year":"2013","unstructured":"Acaster S, Gaugris S, Velikova G, Yong K, Lloyd AJ (2013) Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey. Support Care Cancer 21(2):599\u2013607. https:\/\/doi.org\/10.1007\/s00520-012-1548-y","journal-title":"Support Care Cancer"},{"key":"4356_CR26","doi-asserted-by":"publisher","unstructured":"Boland EG, Selvarajah D, Hunter M, Ezaydi Y, Tesfaye S, Ahmedzai SH, Snowden JA, Wilkinson ID (2014) Central pain processing in chronic chemotherapy-induced peripheral neuropathy: a functional magnetic resonance imaging study. PloS one 9(5). https:\/\/doi.org\/10.1371\/journal.pone.0096474","DOI":"10.1371\/journal.pone.0096474"},{"issue":"5","key":"4356_CR27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cncr.29119","volume":"121","author":"EE Kent","year":"2015","unstructured":"Kent EE, Ambs A, Mitchell SA, Clauser SB, Smith AW, Hays RD (2015) Health-related quality of life in older adult survivors of selected cancers: data from the SEER-MHOS linkage. Cancer 121(5):758\u2013765. https:\/\/doi.org\/10.1002\/cncr.29119","journal-title":"Cancer"},{"issue":"5","key":"4356_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"4356_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1046\/j.1365-2141.1996.352889.x","volume":"92","author":"F Wisloff","year":"1996","unstructured":"Wisloff F, Eika S, Hippe E, Hjorth M, Holmberg E, Kaasa S, Palva I, Westin J (1996) Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol 92(3):604\u2013613","journal-title":"Br J Haematol"},{"key":"4356_CR30","volume-title":"The EORTC QLQ-C30 scoring manual","author":"P Fayers","year":"2001","unstructured":"Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels","edition":"3"},{"key":"4356_CR31","doi-asserted-by":"crossref","unstructured":"Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lanteri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R, Group EQoL (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer (Oxford, England : 1990) 41 (8):1135\u20131139","DOI":"10.1016\/j.ejca.2005.02.012"},{"issue":"11","key":"4356_CR32","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s11136-017-1626-1","volume":"26","author":"JM Kieffer","year":"2017","unstructured":"Kieffer JM, Postma TJ, van de Poll-Franse L, Mols F, Heimans JJ, Cavaletti G, Aaronson NK (2017) Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20). Qual Life Res 26(11):2999\u20133010. https:\/\/doi.org\/10.1007\/s11136-017-1626-1","journal-title":"Qual Life Res"},{"issue":"9","key":"4356_CR33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606\u2013613","journal-title":"J Gen Intern Med"},{"key":"4356_CR34","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1007\/s00520-017-3780-y","volume":"25","author":"J Le-Rademacher","year":"2017","unstructured":"Le-Rademacher J, Kanwar R, Seisler D, Pachman DR, Qin R, Abyzov A, Ruddy KJ, Banck MS, Lavoie Smith EM, Dorsey SG, Aaronson NK, Sloan J, Loprinzi CL, Beutler AS (2017) Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel\/carboplatin-induced peripheral neuropathy in NCCTG\/Alliance clinical trials. Support Care Cancer 25:3537\u20133544. https:\/\/doi.org\/10.1007\/s00520-017-3780-y","journal-title":"Support Care Cancer"},{"key":"4356_CR35","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1007\/s00520-018-4553-y","volume":"27","author":"EML Smith","year":"2018","unstructured":"Smith EML, Zanville N, Kanzawa-Lee G, Donohoe C, Bridges C, Loprinzi C, Le-Rademacher J, Yang JJ (2018) Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data. Support Care Cancer 27:2599\u20132608. https:\/\/doi.org\/10.1007\/s00520-018-4553-y","journal-title":"Support Care Cancer"},{"issue":"1","key":"4356_CR36","doi-asserted-by":"publisher","first-page":"107327481875660","DOI":"10.1177\/1073274818756608","volume":"25","author":"EML Smith","year":"2018","unstructured":"Smith EML, Knoerl R, Yang JJ, Kanzawa-Lee G, Lee D, Bridges CM (2018) In search of a gold standard patient-reported outcome measure for use in chemotherapy-induced peripheral neuropathy clinical trials. Cancer Control 25(1):1073274818756608. https:\/\/doi.org\/10.1177\/1073274818756608","journal-title":"Cancer Control"},{"issue":"6","key":"4356_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/0164027504268574","volume":"26","author":"ME Hughes","year":"2004","unstructured":"Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT (2004) A short scale for measuring loneliness in large surveys: results from two population-based studies. Res Aging 26(6):655\u2013672. https:\/\/doi.org\/10.1177\/0164027504268574","journal-title":"Res Aging"},{"issue":"10","key":"4356_CR38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, Lowe B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166(10):1092\u20131097. https:\/\/doi.org\/10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"issue":"12","key":"4356_CR39","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/00005650-200412000-00006","volume":"42","author":"B Lowe","year":"2004","unstructured":"Lowe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K (2004) Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 42(12):1194\u20131201","journal-title":"Med Care"},{"issue":"10","key":"4356_CR40","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00127-016-1279-3","volume":"51","author":"M Lasgaard","year":"2016","unstructured":"Lasgaard M, Friis K, Shevlin M (2016) \u201cWhere are all the lonely people?\u201d A population-based study of high-risk groups across the life span. Soc Psychiatry Psychiatr Epidemiol 51(10):1373\u20131384. https:\/\/doi.org\/10.1007\/s00127-016-1279-3","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"2","key":"4356_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejca.2004.10.017","volume":"41","author":"D Osoba","year":"2005","unstructured":"Osoba D, Bezjak A, Brundage M, Zee B, Tu D, Pater J (2005) Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the National Cancer Institute of Canada clinical trials group. Eur J Cancer 41(2):280\u2013287. https:\/\/doi.org\/10.1016\/j.ejca.2004.10.017","journal-title":"Eur J Cancer"},{"issue":"5","key":"4356_CR42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"key":"4356_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40814-019-0518-2","volume":"5","author":"RF Larsen","year":"2019","unstructured":"Larsen RF, Jarden M, Minet LR, Frolund UC, Abildgaard N (2019) Supervised and home-based physical exercise in patients newly diagnosed with multiple myeloma-a randomized controlled feasibility study. Pilot Feasibility Stud 5:130. https:\/\/doi.org\/10.1186\/s40814-019-0518-2","journal-title":"Pilot Feasibility Stud"},{"issue":"13","key":"4356_CR44","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","volume":"125","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, Offidani M, McCarthy P, Evangelista A, Lonial S, Zweegman S, Musto P, Terpos E, Belch A, Hajek R, Ludwig H, Stewart AK, Moreau P, Anderson K, Einsele H, Durie BG, Dimopoulos MA, Landgren O, San Miguel JF, Richardson P, Sonneveld P, Rajkumar SV (2015) Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood 125(13):2068\u20132074. https:\/\/doi.org\/10.1182\/blood-2014-12-615187","journal-title":"Blood"},{"key":"4356_CR45","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","volume":"185","author":"S Katz","year":"1963","unstructured":"Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function. Jama 185:914\u2013919","journal-title":"Jama"},{"issue":"3","key":"4356_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist 9(3):179\u2013186","journal-title":"The Gerontologist"},{"key":"4356_CR47","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/cam4.1128","volume":"6","author":"H Gregersen","year":"2017","unstructured":"Gregersen H, Vangsted AJ, Abildgaard N, Andersen NF, Pedersen RS, Frolund UC, Helleberg C, Broch B, Pedersen PT, Gimsing P, Klausen TW (2017) The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study. Cancer Med 6:1807\u20131816. https:\/\/doi.org\/10.1002\/cam4.1128","journal-title":"Cancer Med"},{"issue":"6","key":"4356_CR48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3109\/0284186X.2013.875625","volume":"53","author":"TA Horsboel","year":"2014","unstructured":"Horsboel TA, Nielsen CV, Andersen NT, Nielsen B, de Thurah A (2014) Risk of disability pension for patients diagnosed with haematological malignancies: a register-based cohort study. Acta Oncol (Stockholm, Sweden) 53(6):724\u2013734. https:\/\/doi.org\/10.3109\/0284186X.2013.875625","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"key":"4356_CR49","doi-asserted-by":"publisher","unstructured":"Mohty M, Terpos E, Mateos MV, Cavo M, Lejniece S, Beksac M, Bekadja MA, Legiec W, Dimopoulos M, Stankovic S, Duran MS, De Stefano V, Corso A, Kochkareva Y, Laane E, Berthou C, Salwender H, Masliak Z, Peceliunas V, Willenbacher W, Silva J, Louw V, Nemet D, Borbenyi Z, Abadi U, Pedersen RS, Cernelc P, Potamianou A, Couturier C, Feys C, Thoret-Bauchet F, Boccadoro M (2018) Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, noninterventional study. Clin Lymphoma Myeloma Leuk. https:\/\/doi.org\/10.1016\/j.clml.2018.06.018","DOI":"10.1016\/j.clml.2018.06.018"},{"key":"4356_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ctrv.2016.11.010","volume":"52","author":"LM Buffart","year":"2017","unstructured":"Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galvao DA, Chinapaw MJ, Steindorf K, Irwin ML, Stuiver MM, Hayes S, Griffith KA, Lucia A, Mesters I, van Weert E, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M, Thorsen L, Schulz KH, Short CE, James EL, Plotnikoff RC, Arbane G, Schmidt ME, Potthoff K, van Beurden M, Oldenburg HS, Sonke GS, van Harten WH, Garrod R, Schmitz KH, Winters-Stone KM, Velthuis MJ, Taaffe DR, van Mechelen W, Kersten MJ, Nollet F, Wenzel J, Wiskemann J, Verdonck-de Leeuw IM, Brug J (2017) Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev 52:91\u2013104. https:\/\/doi.org\/10.1016\/j.ctrv.2016.11.010","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"4356_CR51","doi-asserted-by":"publisher","first-page":"E326","DOI":"10.1188\/14.onf.e326-e342","volume":"41","author":"SI Mishra","year":"2014","unstructured":"Mishra SI, Scherer RW, Snyder C, Geigle P, Gotay C (2014) Are exercise programs effective for improving health-related quality of life among cancer survivors? A systematic review and meta-analysis. Oncol Nurs Forum 41(6):E326\u2013E342. https:\/\/doi.org\/10.1188\/14.onf.e326-e342","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"4356_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41408-019-0187-7","volume":"9","author":"C Kyriakou","year":"2019","unstructured":"Kyriakou C, Molloy S, Vrionis F, Alberico R, Bastian L, Zonder JA, Giralt S, Raje N, Kyle RA, Roodman DGD, Dimopoulos MA, Rajkumar SV, Durie BBG, Terpos E (2019) The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG). Blood Cancer J 9(3):27. https:\/\/doi.org\/10.1038\/s41408-019-0187-7","journal-title":"Blood Cancer J"},{"issue":"7","key":"4356_CR53","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","volume":"3","author":"KM Mustian","year":"2017","unstructured":"Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM (2017) Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 3(7):961\u2013968. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6914","journal-title":"JAMA Oncol"},{"issue":"11","key":"4356_CR54","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.apmr.2011.06.013","volume":"92","author":"R Barclay-Goddard","year":"2011","unstructured":"Barclay-Goddard R, Lix LM, Tate R, Weinberg L, Mayo NE (2011) Health-related quality of life after stroke: does response shift occur in self-perceived physical function? Arch Phys Med Rehabil 92(11):1762\u20131769. https:\/\/doi.org\/10.1016\/j.apmr.2011.06.013","journal-title":"Arch Phys Med Rehabil"},{"issue":"9","key":"4356_CR55","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s11136-019-02195-9","volume":"28","author":"M Friedrich","year":"2019","unstructured":"Friedrich M, Karoff J, Hinz A (2019) Response shift effects in patients\u2019 assessments of their quality of life after cardiac rehabilitation. Qual Life Res 28(9):2609\u20132620. https:\/\/doi.org\/10.1007\/s11136-019-02195-9","journal-title":"Qual Life Res"},{"issue":"7","key":"4356_CR56","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1023\/a:1008305523548","volume":"10","author":"MA Sprangers","year":"1999","unstructured":"Sprangers MA, Schwartz CE (1999) The challenge of response shift for quality-of-life-based clinical oncology research. Ann Oncol 10(7):747\u2013749. https:\/\/doi.org\/10.1023\/a:1008305523548","journal-title":"Ann Oncol"},{"issue":"7296","key":"4356_CR57","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.322.7296.1240","volume":"322","author":"AJ Carr","year":"2001","unstructured":"Carr AJ, Gibson B, Robinson PG (2001) Measuring quality of life: is quality of life determined by expectations or experience? BMJ (Clin Res Ed) 322(7296):1240\u20131243","journal-title":"BMJ (Clin Res Ed)"},{"issue":"4","key":"4356_CR58","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/(sici)1099-1611(199907\/08)8:4<344::aid-pon399>3.0.co;2-t","volume":"8","author":"CE Schwartz","year":"1999","unstructured":"Schwartz CE, Feinberg RG, Jilinskaia E, Applegate JC (1999) An evaluation of a psychosocial intervention for survivors of childhood cancer: paradoxical effects of response shift over time. Psychooncology 8(4):344\u2013354. https:\/\/doi.org\/10.1002\/(sici)1099-1611(199907\/08)8:4<344::aid-pon399>3.0.co;2-t","journal-title":"Psychooncology"},{"issue":"7","key":"4356_CR59","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ijnurstu.2006.03.015","volume":"43","author":"P Moons","year":"2006","unstructured":"Moons P, Budts W, De Geest S (2006) Critique on the conceptualisation of quality of life: a review and evaluation of different conceptual approaches. Int J Nurs Stud 43(7):891\u2013901","journal-title":"Int J Nurs Stud"},{"issue":"11","key":"4356_CR60","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1177\/0269215514532478","volume":"28","author":"J Richardson","year":"2014","unstructured":"Richardson J, Loyola-Sanchez A, Sinclair S, Harris J, Letts L, MacIntyre NJ, Wilkins S, Burgos-Martinez G, Wishart L, McBay C, Martin Ginis K (2014) Self-management interventions for chronic disease: a systematic scoping review. Clin Rehabil 28(11):1067\u20131077. https:\/\/doi.org\/10.1177\/0269215514532478","journal-title":"Clin Rehabil"},{"issue":"2","key":"4356_CR61","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.apmr.2011.09.010","volume":"93","author":"R Barclay-Goddard","year":"2012","unstructured":"Barclay-Goddard R, King J, Dubouloz CJ, Schwartz CE (2012) Building on transformative learning and response shift theory to investigate health-related quality of life changes over time in individuals with chronic health conditions and disability. Arch Phys Med Rehabil 93(2):214\u2013220. https:\/\/doi.org\/10.1016\/j.apmr.2011.09.010","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"4356_CR62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3138\/ptc-2018-0047","volume":"71","author":"J King","year":"2019","unstructured":"King J, Barclay R, Ripat J, Dubouloz CJ, Schwartz CE (2019) An investigation of occupational therapists\u2019 and physical therapists\u2019 perspectives on the process of change that occurs among clients during rehabilitation, including their use of response shift and transformative learning. Physiother Can 71(4):355\u2013366. https:\/\/doi.org\/10.3138\/ptc-2018-0047","journal-title":"Physiother Can"},{"key":"4356_CR63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.critrevonc.2015.11.005","volume":"98","author":"JH Gan","year":"2015","unstructured":"Gan JH, Sim CY, Santorelli LA (2015) The effectiveness of exercise programmes in patients with multiple myeloma: a literature review. Crit Rev Oncol Hematol 98:275\u2013289. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.11.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"4356_CR64","unstructured":"DMSG (2017) Diagnostic and treatment of multiple myeloma. Danish Myeloma Study Group. \u00a0http:\/\/myeloma.hematology.dk\/index.php\/vejledninger-dmsg. Accessed\u00a06\u00a0Nov 2020"},{"issue":"Supplement 2","key":"4356_CR65","first-page":"294","volume":"2","author":"L Nielsen","year":"2018","unstructured":"Nielsen L, Jarden M, Andersen C, Frederiksen H, Gregersen H, Klostergaard A, Steffensen M, Pedersen P, Broch B, Frederiksen M, Jensen B, Helleberg C, Mylin A, Abildgaard N (2018) Quality of life in newly diagnosed and relapsed danish multiple myeloma patients-a national longitudinal study of danish myeloma study group. HemaSphere 2(Supplement 2):294\u2013295","journal-title":"HemaSphere"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04356-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04356-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04356-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T05:05:41Z","timestamp":1628658341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04356-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4356"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04356-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"5 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"LKN received research funding from the University of Southern Denmark, Celgene, Takeda, Amgen and Janssen. RFL received funding from Amgen. LJ, EJ and SM declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Oral and written consent for participation was a requirement for participation in the study. The research was conducted in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments. According to Danish regulations, approval from The Danish National Committee on Health Research Ethics was not necessary. The study was registered at the Danish Data Protection Agency by number 19\/19123.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}